Skip to main content
. 2017 Jun 13;17(5):395–402. doi: 10.1038/tpj.2017.21

Table 1. Drugs from the FDA Table of Pharmacogenomic Biomarkers in Drug Labeling included in literature review.

Therapeutic area Count Drugs
Oncology 11 Capecitabine, cisplatin, dabrafenib, fluorouracil, irinotecan, lapatinib, mercaptopurine, nilotinib, pazopanib, rasburicase, thioguanine
Infectious diseases 10 Abacavir, chloroquine, dapsone, mafenide, nalidixic acid, nitrofurantoin, primaquine, quinine sulphate, rifampin+isoniazid+pyrazinamidea, sulfamethoxazole+trimethoprima
Psychiatry 9 Aripiprazole, atomoxetine, citalopram, clozapine, fluvoxamine, iloperidone, perphenazine, pimozide, thioridazine
Neurology 8 Carbamazepine, clobazam, dextromethorphan+quinidinea, divalproex, phenytoin, tetrabenazine, valproic acid, vortioxetine
Cardiology 5 Carvedilol, clopidogrel, isosorbide+hydralazinea, metoprolol, propafenone
Gastroenterology 5 Dexlansoprazole, esomeprazole, metoclopramide, PEG-3350+sodium sulphate+sodium chloride+potassium chloride+sodium ascorbate+ascorbic acida, rabeprazole
Rheumatology 5 Azathioprine, carisoprodol, celecoxib, flurbiprofen, pegloticase
Endocrinology 4 Chlorpropamide, glimepiride, glipizide, glyburide
Haematology 3 Eltrombopag, methylene blue, warfarin
Analgesic 1 Tramadol
Anaesthesiology 1 Codeine
Dental 1 Cevimeline
Genitourinary 1 Tolterodine
Inborn errors of metabolism 1 Eliglustat
Pulmonary 1 Ivacaftor
Toxicology 1 Sodium nitrite
Transplantation 1 Mycophenolic acid

Abbreviation: FDA, Food and Drug Administration.

Drugs in bold had economic evaluations available.

a

Multiple drugs on a single FDA label.